Rainbow Childrens Medicare Intrinsic Value
Rainbow Childrens Medicare (RAINBOW) median intrinsic value is ₹436.41 from 10 valuation models (range ₹291–₹727), vs current price ₹1454.70 — -70.0% downside (Trading Above Calculated Value), margin of safety -100.0%. See Rainbow Childrens Medicare P/B ratio trends to compare market price against book value per share.
RAINBOW Valuation Methods Summary — DCF, Graham Number & P/E
Rainbow Childrens Medicare intrinsic value across 10 models vs current price ₹1454.70 — upside/downside and value range per method. For current market price and key ratios, visit Rainbow Childrens Medicare share price chart.
| Method | Type | Intrinsic Value | Range | Upside/Downside | Details |
|---|---|---|---|---|---|
| P/E Based Valuation | earnings | ₹436.41 | ₹349.13 - ₹523.69 | -70.0% | EPS: ₹30.36, Sector P/E: 12x |
| Book Value Method | asset | ₹290.94 | ₹261.85 - ₹320.03 | -80.0% | Book Value/Share: ₹163.14, P/B: 1.0x |
| Revenue Multiple Method | revenue | ₹436.41 | ₹392.77 - ₹480.05 | -70.0% | Revenue/Share: ₹182.35, P/S: 0.8x |
| EBITDA Multiple Method | earnings | ₹581.88 | ₹523.69 - ₹640.07 | -60.0% | EBITDA: ₹592.00Cr, EV/EBITDA: 6x |
| Simple DCF (5Y) | dcf | ₹581.88 | ₹465.50 - ₹698.26 | -60.0% | CF Growth: 15.0%, Discount: 15% |
| PEG Ratio Method | growth | ₹436.41 | ₹392.77 - ₹480.05 | -70.0% | EPS Growth: 8.0%, Fair P/E: 6.4x |
| Growth Adjusted P/E | growth | ₹436.41 | ₹392.77 - ₹480.05 | -70.0% | Revenue Growth: 6.0%, Adj P/E: 8.2x |
| ROE Based Valuation | profitability | ₹727.35 | ₹654.62 - ₹800.09 | -50.0% | ROE: 18.8%, P/E Multiple: 14x |
| Graham Defensive Method | conservative | ₹436.41 | ₹392.77 - ₹480.05 | -70.0% | EPS: ₹30.36, BVPS: ₹163.14 |
| Dividend Yield Method | dividend | ₹436.41 | ₹392.77 - ₹480.05 | -70.0% | DPS: ₹3.50, Target Yield: 3.5% |
RAINBOW Intrinsic Value vs Market Price — All Valuation Models
Rainbow Childrens Medicare fair value range ₹291–₹727 vs current market price ₹1454.70 across 10 valuation models. Check Rainbow Childrens Medicare market worth to track the company's total market size over time.
RAINBOW Intrinsic Value Analysis — Undervalued or Overvalued?
Rainbow Childrens Medicare median intrinsic value ₹436.41, current price ₹1454.70 — Trading Above Calculated Value by 70.0%, margin of safety -100.0%.
What is the intrinsic value of RAINBOW?
Based on our comprehensive analysis using 10 different valuation methods, the estimated intrinsic value of Rainbow Childrens Medicare (RAINBOW) is ₹436.41 (median value). With the current market price of ₹1454.70, this represents a -70.0% variance from our estimated fair value.
The valuation range spans from ₹290.94 to ₹727.35, indicating ₹290.94 - ₹727.35.
Is RAINBOW undervalued or overvalued?
Based on our multi-method analysis, Rainbow Childrens Medicare (RAINBOW) appears to be trading above calculated value by approximately 70.0%.
RAINBOW Financial Health — Key Ratios vs Industry Benchmarks
Rainbow Childrens Medicare financial ratios — ROE, debt-to-equity, profit margins and liquidity vs industry benchmarks and their impact on intrinsic value.
| Financial Metric | Current Value | Industry Benchmark | Assessment | Impact on Valuation |
|---|---|---|---|---|
| Current Ratio | 0.72 | Industry Standard: 2.0+ | Below 1.5 | Measures short-term liquidity capacity |
| Return on Equity | 18.8% | Industry Standard: 15%+ | Above 15% | Measures shareholder return efficiency |
| Operating Margin | 31.0% | Industry Standard: 20%+ | Above 20% | Indicates operational efficiency level |
| Asset Turnover Ratio | 0.67x | Industry Standard: 1.0x+ | Above 0.5x | Measures asset utilization efficiency |
RAINBOW Cash Flow Quality — Operating & Free Cash Flow
Rainbow Childrens Medicare operating cash flow, free cash flow, quality rating and sustainability score by period — key inputs to DCF intrinsic value calculation.
| Period | Operating Cash Flow | Free Cash Flow | Cash Flow Quality | Sustainability Score |
|---|---|---|---|---|
| March 2026 | ₹420 Cr | ₹291 Cr | Positive Free Cash Flow | 8/10 |
| March 2025 | ₹396 Cr | ₹262 Cr | Positive Free Cash Flow | 8/10 |
| March 2024 | ₹321 Cr | ₹208 Cr | Positive Free Cash Flow | 8/10 |
| March 2023 | ₹329 Cr | ₹97 Cr | Positive Free Cash Flow | 7/10 |
| March 2022 | ₹224 Cr | ₹137 Cr | Positive Free Cash Flow | 8/10 |